HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRODUCTIVE INFECTION IN STAUROSPORINE-BLOCKED QUIESCENT CELLS

被引:2
|
作者
ARANDAANZALDO, A
VIZA, D
机构
[1] URA-CNRS, Laboratoire d'Immumobiologie, Facultè de Mèdecine, 75006 Paris, 45, rue des Saints-Pères
关键词
PROTEIN KINASE INHIBITOR; VIRAL INFECTIVITY; CELL CYCLE; T-CELL;
D O I
10.1016/0014-5793(92)81268-Q
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Staurosporine, an antibiotic known to inhibit cellular protein kinases, can reversibly block the progress of normal and tumour cells into the cell cycle. The ability of HIV-1 to infect and replicate in cells blocked by staurosporine was investigated. The results show that blocked, non-cycling cells can be productively infected by HIV-1, steadily releasing infectious progeny virus for several weeks. This suggests that at least in some cases. HIV-1 can be found in a stable and active state in resting, non-proliferating T cells.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [41] HIV-1 (HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1) - INFECTION AND DETECTION
    ZEICHHARDT, H
    ZORR, B
    HAMPL, H
    WILLINGMANN, P
    BUCHOW, H
    MAXEINER, HG
    HABERMEHL, KO
    ARZTLICHE LABORATORIUM, 1987, 33 (11): : 253 - 258
  • [42] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF HUMAN PLACENTA - POTENTIAL ROUTE FOR FETAL INFECTION
    AMIRHESSAMIAGHILI, N
    SPECTOR, SA
    JOURNAL OF VIROLOGY, 1991, 65 (05) : 2231 - 2236
  • [43] THE ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS IN VIRUS-INFECTION
    FREED, EO
    MARTIN, MA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) : 23883 - 23886
  • [44] MYCOBACTERIUM-TUBERCULOSIS IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    KHOURI, YF
    MASTRUCCI, MT
    HUTTO, C
    MITCHELL, CD
    SCOTT, GB
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (11) : 950 - 955
  • [45] INFECTION OF MACACA-NEMESTRINA BRAIN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    FRUMKIN, LR
    PATTERSON, BK
    LEVERENZ, JB
    AGY, MB
    WOLINSKY, SM
    MORTON, WR
    COREY, L
    JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 2467 - 2476
  • [46] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AMONG LEPROSY PATIENTS IN ZAIRE
    LUCAS, SB
    FINE, PEM
    STERNE, JAC
    PONNIGHAUS, JM
    TURNER, AC
    DECOCK, KM
    ZUCKERMAN, M
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02): : 502 - 503
  • [47] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CANDIDATE VACCINE BREAKTHROUGH INFECTION - REPLY
    KAHN, JO
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06): : 1637 - 1638
  • [48] IMMUNE FACTORS INFLUENCING ACUTE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    SAFRIT, JT
    CAO, YZ
    ANDREWS, CA
    HO, DD
    KOUP, RA
    CLINICAL RESEARCH, 1993, 41 (02): : A222 - A222
  • [49] SEROPREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN ZAMBIAN CHILDREN WITH TUBERCULOSIS
    CHINTU, C
    BHAT, G
    LUO, C
    RAVIGLIONE, M
    DIWAN, V
    DUPONT, HL
    ZUMLA, A
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (06) : 499 - 504
  • [50] LUETIC CERVICAL ADENITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HELLER, H
    FROMOWITZ, F
    FUHRER, J
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1992, 118 (07) : 757 - 758